Overview

A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

Pantovigar - a high effective product designed primarily for the treatment of diffuse hair loss in women as well as for the treatment of damaged hair, in the combined therapy can be successfully applied in other types of alopecia. The purpose of this study is to evaluate efficacy and tolerability of combination therapy Pantovigar plus 2% minoxidil vs 2% minoxidil. To collect tolerability data for combined treatment Pantovigar plus 2% Minoxidil course therapy.

Phase:

Phase 2

Details

Lead Sponsor:

Merz Pharmaceuticals GmbH

Collaborator:

LLC Merz Pharma, Russia

Treatments:

Minoxidil